Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
1. Clinical Value of Serum S100A8/A9 and CA15-3 in the Diagnosis of Breast Cancer

Samaneh Khorrami; Masoumeh Tavakoli; Elahe Safari

Volume 14, Issue 2 , Spring 2019, , Pages 104-112

http://dx.doi.org/10.30699/ijp.14.2.104

Abstract
  Background and Objective: S100A8/A9 is a heterodimer calcium-binding protein which is involved in tumor cell proliferation, adhesion and invasion, and is proposed as a biomarker for better diagnosis and prognosis in many cancers. The aim of this study was to evaluate the simultaneous serum-based level ...  Read More

2. Application and Assessment of Allogeneic Fibroblasts for Cell Therapy

Seyedeh Mehrnaz Kouhbanani nejad; Farzaneh Armin; Shahriar dabiri; Ali Derakhshani; Maryam Iranpour; Alireza Farsinejad

Volume 13, Issue 4 , Autumn 2018, , Pages 454-460

Abstract
  Background and Objective: In recent years, due to increasing number of patients with non-healing skin ulcers, skin substitutes have been used. Skin substitutes contain living cells causing faster and more effective wound healing. Therefore, research on the use of autologous and allogeneic cells such ...  Read More

3. Tissue Expression of Prohibition-I and Its Relationship With Prognostic Factors in Breast Cancer

Hossein Javid; Isaac Hashemy; Soudabeh Shahid sales; Nema Mohammadian Roshan; Tayyebeh Kianoosh; Farnaz Zahedi Avval

Volume 13, Issue 2 , Spring 2018, , Pages 237-244

http://dx.doi.org/10.30699/ijp.13.2.237

Abstract
  Background & objective: Globally, breast cancer is the most common malignancy among females. Prohibition (PHB)-I, a homologous protein, was initially introduced as a suppressor gene for amplification process. Further, the protein has a key role in the cell cycle and is capable of inhibiting ...  Read More